A DIFFERENT vaccine: OHSU part of HIV vax going to human trials
February 19, 2021
Klaus Freuh, Ph.D., describes his involvement in developing a cytomegalovirus-based HIV vaccine candidate that is now being tested in a Phase 1 clinical trial sponsored by Vir Biotechnology.